Clinical trial
A Comparison of EpiCept™ NP-1 Topical Cream vs. Oral Gabapentin in Postherpetic…
NCT00475904 · EpiCept Corporation, Industry · Completed
Key facts
| NCT number | NCT00475904 |
|---|---|
| Title | A Comparison of EpiCept™ NP-1 Topical Cream vs. Oral Gabapentin in Postherpetic Neuralgia (PHN) |
| Official title | A Phase II, Double-Blind, Randomized, Placebo-Controlled Non-inferiority Trial of EpiCept™ NP-1 Topical Cream (2% Ketamine / 4% Amitriptyline) vs. Oral Gabapentin in Postherpetic Neuralgia (PHN) |
| Lead sponsor | EpiCept Corporation, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Post Herpetic Neuralgia, PHN, Neuropathy, Nerve Pain |
| Intervention type | Drug |
| Interventions | EpiCept-NP-1 Cream, Gabapentin Capsules, placebo |
| Enrollment | 360 |
| Start date | Jul 1, 2007 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | May 21, 2007 |
| Last update posted | Jul 27, 2011 |
| Countries | India |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: